Note: Ingredients listed on restricted chemical lists
EC/CAS
248-740-5/9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
50-90
EC/CAS
202-966-0/101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
25 - 60
General Information
Version
9.0
Revision date
2024-09-27
Product name
CP 620, B
1.2.1 Relevant identified uses
Professional use
Emergency telephone
+49 (0)6132-84463, +33 1 45 42 59 59
Icons in SDS
Company Information
company name
Address
e-mail address of the competent person responsible for the Safety Data Sheet
fr-contactez-nous@hilti.com, product.compliance-fire.protection@hilti.com
GHS Information
Signal word
Contains Hazard statements (CLP
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H332, H334, H335, H351, H373
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. Harmful if inhaled. May cause respiratory irritation. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled. 2.2. Label elements Labelling
Hazard pictograms
GHS07 GHS08
Signal word
Contains Hazard statements (CLP) Danger 4,4'-diphenylmethanediisocyanate, isomeres and homologues H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H332 - Harmful if inhaled. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 - May cause respiratory irritation. H351 - Suspected of causing cancer. H373 - May cause damage to organs through prolonged or repeated exposure.
Precautionary statements
P260 - Do not breathe vapours. P280 - Wear protective gloves, protective clothing, eye protection. P284 - In case of inadequate ventilation wear respiratory protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P342+P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.
Additional information
2.3. Other hazards As from 24 August 2023 adequate training is required before industrial or professional use. Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component 4,4'-diphenylmethanediisocyanate, isomeres and homologues (9016-87-9) Reaction products of phosphoryl trichloride and 2- methyloxirane (TCPP) (1244733-77-4) 4,4'-methylenediphenyl diisocyanate; diphenylmethane-4,4'-diisocyanate (101-68-8) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component 4,4'-diphenylmethanediisocyanate, isomeres and homologues (9016-87-9) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Component 4,4'-methylenediphenyl diisocyanate; diphenylmethane-4,4'-diisocyanate (101-68-8) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Reaction products of phosphoryl trichloride and 2- methyloxirane (TCPP) (1244733-77-4) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605